VI Biotherapeutics

Company Overview

Snapshot

Founded in June 2024, VI Biotherapeutics operates in stealth mode with 1–10 employees. The company has secured funding across two rounds, including a grant from the Israel Innovation Authority in January 2025.

Business overview

VI Biotherapeutics is a stealth-mode company operating within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology. While details about its core product or technology are not publicly disclosed, the company is engaged in research and development, indicating a focus on creating innovative solutions within the pharmaceutical and medical biotechnology markets.

Company Intelligence Q&A

When was VI Biotherapeutics founded?

VI Biotherapeutics was founded in June 2024.

What is VI Biotherapeutics' primary sector?

VI Biotherapeutics operates primarily in the Health Tech & Life Sciences sector, with a specific focus on Pharma & Medical Biotechnology.

Has VI Biotherapeutics received any grants?

Yes, in January 2025, VI Biotherapeutics secured a grant from the Israel Innovation Authority.

What is the current employee count for VI Biotherapeutics?

VI Biotherapeutics currently has 1–10 employees.

What is the current product stage of VI Biotherapeutics?

VI Biotherapeutics is currently in the R&D product stage, focusing on developing innovative solutions within the pharmaceutical and medical biotechnology markets.